Decoding the role of aldosterone in glycation-induced diabetic complications

Area of Science:

• Endocrinology and Metabolism
• Molecular Biology
• Pathophysiology

Background:

• Diabetes mellitus leads to microvascular and macrovascular complications globally.
• Hyperglycemia drives advanced glycation end product (AGE) formation, activating the Receptor for AGEs (RAGE) pathway, causing inflammation, oxidative stress, and fibrosis.
• Hyperglycemia also increases aldosterone (Aldo) secretion, which, via the mineralocorticoid receptor (MR), promotes inflammation and fibrosis through genomic and non-genomic mechanisms.

Purpose of the Study:

• To review the current understanding of the AGEs-RAGE and Aldo-MR pathways in diabetic complications.
• To investigate the unresolved cross-talk between these two critical pathways.
• To highlight potential mutual molecular targets for therapeutic intervention in diabetic nephropathy (DN) and cardiovascular diseases (CVDs).

Main Methods:

• Literature review of existing research on AGEs-RAGE and Aldo-MR pathways.
• Analysis of studies investigating the interplay between glycation and aldosterone signaling.
• Focus on molecular mechanisms and clinical significance.

Main Results:

• Both AGEs-RAGE and Aldo-MR pathways are independently implicated in the pathogenesis of DN and CVDs.
• Evidence suggests significant interactions and mutual repercussions between these pathways.
• The precise nature of the cross-talk remains incompletely elucidated.

Conclusions:

• Understanding the cross-talk between AGEs-RAGE and Aldo-MR pathways is crucial for developing effective therapies for diabetic complications.
• Targeting these interconnected pathways may offer novel therapeutic strategies for DN and CVDs.
• Further research is warranted to fully elucidate the molecular interactions and clinical implications.